Dextran sulphate cellulose columns for the treatment of nephrotic syndrome due to inactive lupus nephritis

Nephrology Dialysis Transplantation

Volumn 15, Issue 2, 2000, Pages 235-238

  Daimon, Shoichiro ^a,c   Saga, Tsutomu ^a   Nakayama, Miho ^a   Nomura, Yumi ^a   Chikaki, Hajime ^a   Kazushi, Dan ^a   Koni, Ichiro ^b  

^a Maizuru Kyosai Hospital   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Maizuru Kyosai Hospital   (Japan)

Author keywords

Dextran sulphate cellulose column; Nephrotic syndrome; Systemic lupus erythematosus

Indexed keywords

CELLULOSE; CYCLOSPORIN A; METHYLPREDNISOLONE; MIZORIBINE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; FEMALE; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHROSIS; OLIGURIA; PLASMAPHERESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0033955862     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.2.235     Document Type: Article

References (22)

1. Felson DT, Anderson J. Evidence for the superiority of immuno-suppressive drugs and prednisone over prednisone alone in lupus nephritis: results of a pooled analysis. N Engl J Med 1984; 311: 1528-1533
2. Boumpas DT, Austin HA III, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992; 340: 741-745
3. Bansal VK, Beto JA. Treatment of lupus nephritis: a metaanalysis of clinical trials. Am J Kidney Dis 1997; 29: 193-199
4. Tojyo K, Sakai S, Miyahara T. Possible therapeutic application of low density lipoprotein apheresis in conjunction with double filtration plasma pheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerularsclerosis (FGS). Jpn J Nephrol 1988; 30: 1153-1160
5. Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 1994; 9: 257-264
6. Suzuki K, Hara M, Ishizuka T, Hirose T, Harigai M, Kitani K, Kawagoc M, Nakamura H. Continuous anti-dsDNA antibody apheresis in systemic lupus erythematosus. Lancet 1990; 336: 753-754
7. Kutsuki H, Takata S, Yamamoto K, Tani N. Therapeutic selective adsorption of anti-DNA antibody using dextran cellulose column (Selesorb) for the treatment of systemic lupus erythematosus. Ther Apheresis 1998; 2: 18-24
8. Leaker BR, Becker GJ, Dowling JP, Kincaid-Smith PS. Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression. Clin Nephrol 1986; 25: 236-244
9. Lewis EJ, Hunsicker LG, Shu-Ping Lan MA, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992; 326: 1373-1378
10. Cheigh JS, Stenzel KH. End-stage renal disease in systemic lupus erythematosus. Am J Kidney Dis 1993; 21: 2-8
11. Coplon NS, Diskin CJ, Peterson J, Swenson RS. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med 1983; 308: 186-190
12. Moorhead JF, Chan MK, El-Nafas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; 2: 1309-1311
13. Koenig W, Ditschuneit HH, Hehr R, Grunewald RW, Ernst E, Hombach. Blood rheology after LDL apheresis using dextran sulfate cellulose absorption a case report. Angiology 1992; 43: 606-609
14. Rubba P, Iannuzzi A, Postiglione A, Scarpato N, Montefusco S, Gnasso A, Nappi G, Cortese C, Mancini M. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolema. Circulation 1990; 81: 610-616
15. Mabuchi H, Michishita I, Takeda M, Fujita H. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 1987; 68: 19-25
16. Agishi T, Naganuma S, Nakasato S, Kitajima K, Ota K, Ban K, Nomura M. Treatment of arteriosclerotic obstruction by LDL absorption. Angiology 1991; 44: 222-227
17. van den Born J, van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992; 41: 115-123
18. Berden HM. Lupus nephritis. Kidney Int 1997; 52: 538-558
19. Meyrier A. Antiproteinuric and immunological effects of cyclosporin A in the treatment of glomerular diseases. Nephrol Dial Transplant 1992; [Suppl. 1]: 80-84
20. Meyrier A. Treatment of glomerular disease with cyclosporin A. Nephrol Dial Transplant 1989; 4: 923-931
21. Ingulli E, Tejani A. Severe hypercholesterolemia inhibits Cyclosporin A efficacy in a dose-dependent manner in children with nephrotic syndrome. J Am Soc Nephrol 1992; 3: 254-259
22. Gruppo Italiano per lo Studio della Nefrite Lupica. Lupus nephritis: Prognostic factors and probability of maintaining life-supporting renal function 10 years after diagnosis. Am J Kidney Dis 1992; 19: 473-479